Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.13B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$1.18B |
| 3 |
Apple
AAPL
|
+$836M |
| 4 |
Alibaba
BABA
|
+$807M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$566M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$429M |
| 2 |
Boeing
BA
|
+$402M |
| 3 |
Coty
COTY
|
+$284M |
| 4 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$104M |
| 5 |
Qualcomm
QCOM
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 89.12% |
| 2 | Technology | 2.44% |
| 3 | Consumer Discretionary | 1.83% |
| 4 | Communication Services | 1.72% |
| 5 | Financials | 1.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
PUT
AppFolio
APPF
$8.3B
| $3.23M | ﹤0.01% |
31,600
+19,800
| +168% | +$1.87M |
|
3302
PUT
ProShares UltraShort Yen
YCS
$30.3M
| $3.23M | ﹤0.01% |
176,000
-16,400
| -9% | -$311K |
|
|
HOME
3303
DELISTED
At Home Group Inc.
HOME
| $3.23M | ﹤0.01% |
485,124
+337,525
| +229% | +$5.98M |
|
3304
Direxion Daily Healthcare Bull 3X ETF
CURE
$191M
| $3.23M | ﹤0.01% |
57,554
+28,732
| +100% | +$1.48M |
|
|
VG
3305
PUT
DELISTED
Vonage Holdings Corporation
VG
| $3.23M | ﹤0.01% |
285,000
+184,700
| +184% | +$2M |
|
3306
CALL
Dave & Buster's
PLAY
$327M
| $3.23M | ﹤0.01% |
79,700
+54,700
| +219% | +$2.78M |
|
3307
TechnipFMC
FTI
$29.7B
| $3.22M | ﹤0.01% |
166,663
+103,261
| +163% | +$1.81M |
|
|
ATH
3308
PUT
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $3.22M | ﹤0.01% |
74,700
+58,800
| +370% | +$2.54M |
|
3309
PUT
Lazard
LAZ
$4.25B
| $3.21M | ﹤0.01% |
93,500
-21,600
| -19% | -$774K |
|
3310
PUT
Trinity Industries
TRN
$2.33B
| $3.21M | ﹤0.01% |
154,800
+10,900
| +8% | +$232K |
|
|
CBAY
3311
CALL
DELISTED
Cymabay Therapeutics
CBAY
| $3.21M | ﹤0.01% |
448,300
+382,000
| +576% | +$4.33M |
|
|
PE
3312
PUT
DELISTED
PARSLEY ENERGY INC
PE
| $3.21M | ﹤0.01% |
168,700
+29,600
| +21% | +$566K |
|
3313
CALL
iShares US Technology ETF
IYW
$25.3B
| $3.21M | ﹤0.01% |
64,800
-25,200
| -28% | -$1.23M |
|
|
IDLB
3314
DELISTED
Invesco FTSE International Low Beta Equal Weight ETF
IDLB
| $3.21M | ﹤0.01% |
114,093
+49,952
| +78% | +$1.4M |
|
3315
CALL
HealthEquity
HQY
$7.97B
| $3.2M | ﹤0.01% |
48,900
-18,600
| -28% | -$1.29M |
|
3316
CALL
Glaukos
GKOS
$10.6B
| $3.2M | ﹤0.01% |
42,400
-500
| -1% | -$35.9K |
|
3317
PUT
ProShares Ultra NASDAQ Biotechnology
BIB
$98.9M
| $3.19M | ﹤0.01% |
61,600
-17,300
| -22% | -$861K |
|
|
CS
3318
PUT
DELISTED
Credit Suisse Group
CS
| $3.19M | ﹤0.01% |
266,500
-948,100
| -78% | -$11.5M |
|
3319
PUT
Aramark
ARMK
$15.3B
| $3.19M | ﹤0.01% |
122,434
+74,374
| +155% | +$1.74M |
|
3320
Invesco S&P SmallCap Health Care ETF
PSCH
$185M
| $3.19M | ﹤0.01% |
81,090
-117,567
| -59% | -$4.45M |
|
|
SCHW
3321
Charles Schwab
SCHW
$191B
| $3.19M | ﹤0.01% |
79,304
+68,785
| +654% | +$3M |
|
3322
CALL
Texas Capital Bancshares
TCBI
$4.29B
| $3.19M | ﹤0.01% |
51,900
-4,200
| -7% | -$255K |
|
3323
Viper Energy
VNOM
$15.9B
| $3.18M | ﹤0.01% |
103,295
-87,634
| -46% | -$2.71M |
|
|
AXDX
3324
CALL
DELISTED
Accelerate Diagnostics
AXDX
| $3.18M | ﹤0.01% |
13,910
-36,240
| -72% | -$7.09M |
|
|
TELL
3325
DELISTED
Tellurian Inc.
TELL
| $3.18M | ﹤0.01% |
404,863
+364,048
| +892% | +$3.24M |
|
Similar funds
Jeff Yass's Q2 2019 Portfolio in Review
As of Q2 2019, Jeff Yass held 11,369 positions worth $275B, up 13% from $243B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass deployed $17.9B of net new capital in Q2 2019, opening 2,651 new positions and adding to 3,766 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 14,345,542 shares worth $4.2B.
By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, down from 92% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Walt Disney, an estimated $429M trimmed.
- Jeff Yass's largest Q2 2019 buy was State Street SPDR S&P 500 ETF Trust: 14,345,542 shares worth $4.2B.
- Jeff Yass added most to Alphabet (Google) Class A in Q2 2019, an estimated $1.18B increase.
- Jeff Yass's biggest Q2 2019 reduction was Walt Disney, cutting an estimated $429M.
- Jeff Yass fully exited Goldcorp Inc in Q2 2019, selling an estimated $26.4M.
- Jeff Yass's ten largest holdings make up 24% of its $275B portfolio in Q2 2019.
- Jeff Yass opened 2,651 new positions and closed 1,221 in Q2 2019.
- Jeff Yass's portfolio value rose 13% quarter-over-quarter to $275B.
Based on Susquehanna International Group's 13F filing for Q2 2019, filed 14 Aug 2019.